AustralieFrV1, Main, Exploration, bibRecord, 000294

The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.

Identifieur interne : 000294 ( Main/Exploration ); précédent : 000293; suivant : 000295

The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.

Auteurs : Michael Michael ; Rocio Garcia-Carbonero [Espagne] ; Matthias M. Weber [Allemagne] ; Catherine Lombard-Bohas [France] ; Christos Toumpanakis [Royaume-Uni] ; Rodney J. Hicks [Australie]

Source :

The oncologist [ 1549-490X ] ; 2017.

RBID : pubmed:28220021

Abstract

Neuroendocrine tumors (NETs) are a heterogeneous group of tumors, with >50% of cases involving the gastrointestinal system or pancreas. Somatostatin analogs (SSAs) are used for treating NET-related secretory syndromes and, more recently, for their antiproliferative effects. We conducted a systematic review of published literature on the antiproliferative efficacy and safety of the SSA lanreotide Autogel in the management of NETs to gain a fuller understanding of the evidence and identify future areas of research.

DOI: 10.1634/theoncologist.2016-0305
PubMed: 28220021

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.</title>
<author><name sortKey="Michael, Michael" sort="Michael, Michael" uniqKey="Michael M" first="Michael" last="Michael">Michael Michael</name>
<affiliation><nlm:affiliation>Neuorendocrine Service & Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia Michael.Michael@petermac.org.</nlm:affiliation>
<wicri:noCountry code="subField">Australia Michael.Michael@petermac.org.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Garcia Carbonero, Rocio" sort="Garcia Carbonero, Rocio" uniqKey="Garcia Carbonero R" first="Rocio" last="Garcia-Carbonero">Rocio Garcia-Carbonero</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Universitario Doce de Octubre, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitario Doce de Octubre, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weber, Matthias M" sort="Weber, Matthias M" uniqKey="Weber M" first="Matthias M" last="Weber">Matthias M. Weber</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital Mainz, Mainz, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>University Hospital Mainz, Mainz</wicri:regionArea>
<placeName><region type="land" nuts="2">Rhénanie-Palatinat</region>
<settlement type="city">Mayence</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lombard Bohas, Catherine" sort="Lombard Bohas, Catherine" uniqKey="Lombard Bohas C" first="Catherine" last="Lombard-Bohas">Catherine Lombard-Bohas</name>
<affiliation wicri:level="3"><nlm:affiliation>Hôpital Édouard-Herriot, Fédération des spécialités digestives, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Édouard-Herriot, Fédération des spécialités digestives, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Toumpanakis, Christos" sort="Toumpanakis, Christos" uniqKey="Toumpanakis C" first="Christos" last="Toumpanakis">Christos Toumpanakis</name>
<affiliation wicri:level="3"><nlm:affiliation>Neuroendocrine Tumour Unit, Royal Free Hospital, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Neuroendocrine Tumour Unit, Royal Free Hospital, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hicks, Rodney J" sort="Hicks, Rodney J" uniqKey="Hicks R" first="Rodney J" last="Hicks">Rodney J. Hicks</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Imaging & Neuroendocrine Service & Molecular Imaging and Targeted Therapeutics Laboratory, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Cancer Imaging & Neuroendocrine Service & Molecular Imaging and Targeted Therapeutics Laboratory, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne</wicri:regionArea>
<wicri:noRegion>East Melbourne</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28220021</idno>
<idno type="pmid">28220021</idno>
<idno type="doi">10.1634/theoncologist.2016-0305</idno>
<idno type="wicri:Area/PubMed/Corpus">000F39</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F39</idno>
<idno type="wicri:Area/PubMed/Curation">000F36</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F36</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F36</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F36</idno>
<idno type="wicri:Area/Ncbi/Merge">004346</idno>
<idno type="wicri:Area/Ncbi/Curation">004346</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004346</idno>
<idno type="wicri:Area/Main/Merge">000289</idno>
<idno type="wicri:Area/Main/Curation">000294</idno>
<idno type="wicri:Area/Main/Exploration">000294</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.</title>
<author><name sortKey="Michael, Michael" sort="Michael, Michael" uniqKey="Michael M" first="Michael" last="Michael">Michael Michael</name>
<affiliation><nlm:affiliation>Neuorendocrine Service & Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia Michael.Michael@petermac.org.</nlm:affiliation>
<wicri:noCountry code="subField">Australia Michael.Michael@petermac.org.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Garcia Carbonero, Rocio" sort="Garcia Carbonero, Rocio" uniqKey="Garcia Carbonero R" first="Rocio" last="Garcia-Carbonero">Rocio Garcia-Carbonero</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Universitario Doce de Octubre, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitario Doce de Octubre, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weber, Matthias M" sort="Weber, Matthias M" uniqKey="Weber M" first="Matthias M" last="Weber">Matthias M. Weber</name>
<affiliation wicri:level="3"><nlm:affiliation>University Hospital Mainz, Mainz, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>University Hospital Mainz, Mainz</wicri:regionArea>
<placeName><region type="land" nuts="2">Rhénanie-Palatinat</region>
<settlement type="city">Mayence</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lombard Bohas, Catherine" sort="Lombard Bohas, Catherine" uniqKey="Lombard Bohas C" first="Catherine" last="Lombard-Bohas">Catherine Lombard-Bohas</name>
<affiliation wicri:level="3"><nlm:affiliation>Hôpital Édouard-Herriot, Fédération des spécialités digestives, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Édouard-Herriot, Fédération des spécialités digestives, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Toumpanakis, Christos" sort="Toumpanakis, Christos" uniqKey="Toumpanakis C" first="Christos" last="Toumpanakis">Christos Toumpanakis</name>
<affiliation wicri:level="3"><nlm:affiliation>Neuroendocrine Tumour Unit, Royal Free Hospital, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Neuroendocrine Tumour Unit, Royal Free Hospital, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hicks, Rodney J" sort="Hicks, Rodney J" uniqKey="Hicks R" first="Rodney J" last="Hicks">Rodney J. Hicks</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Imaging & Neuroendocrine Service & Molecular Imaging and Targeted Therapeutics Laboratory, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Cancer Imaging & Neuroendocrine Service & Molecular Imaging and Targeted Therapeutics Laboratory, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne</wicri:regionArea>
<wicri:noRegion>East Melbourne</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">The oncologist</title>
<idno type="eISSN">1549-490X</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Neuroendocrine tumors (NETs) are a heterogeneous group of tumors, with >50% of cases involving the gastrointestinal system or pancreas. Somatostatin analogs (SSAs) are used for treating NET-related secretory syndromes and, more recently, for their antiproliferative effects. We conducted a systematic review of published literature on the antiproliferative efficacy and safety of the SSA lanreotide Autogel in the management of NETs to gain a fuller understanding of the evidence and identify future areas of research.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Espagne</li>
<li>France</li>
<li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Auvergne-Rhône-Alpes</li>
<li>Communauté de Madrid</li>
<li>Grand Londres</li>
<li>Rhénanie-Palatinat</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Londres</li>
<li>Lyon</li>
<li>Madrid</li>
<li>Mayence</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Michael, Michael" sort="Michael, Michael" uniqKey="Michael M" first="Michael" last="Michael">Michael Michael</name>
</noCountry>
<country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Garcia Carbonero, Rocio" sort="Garcia Carbonero, Rocio" uniqKey="Garcia Carbonero R" first="Rocio" last="Garcia-Carbonero">Rocio Garcia-Carbonero</name>
</region>
</country>
<country name="Allemagne"><region name="Rhénanie-Palatinat"><name sortKey="Weber, Matthias M" sort="Weber, Matthias M" uniqKey="Weber M" first="Matthias M" last="Weber">Matthias M. Weber</name>
</region>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Lombard Bohas, Catherine" sort="Lombard Bohas, Catherine" uniqKey="Lombard Bohas C" first="Catherine" last="Lombard-Bohas">Catherine Lombard-Bohas</name>
</region>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Toumpanakis, Christos" sort="Toumpanakis, Christos" uniqKey="Toumpanakis C" first="Christos" last="Toumpanakis">Christos Toumpanakis</name>
</region>
</country>
<country name="Australie"><noRegion><name sortKey="Hicks, Rodney J" sort="Hicks, Rodney J" uniqKey="Hicks R" first="Rodney J" last="Hicks">Rodney J. Hicks</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000294 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000294 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28220021
   |texte=   The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28220021" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.

The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.